Ascletis Pharma Inc. repurchases 4,586,000 shares for approximately HK$54.28 million
I'm PortAI, I can summarize articles.
Ascletis Pharma Inc. has repurchased 4,586,000 shares for approximately HK$54.28 million under its Repurchase Mandate since October 2, 2025. The company increased its share repurchase fund from HK$300 million to HK$500 million, citing significant achievements and the belief that its stock is undervalued. This information was published by Ascletis Pharma Inc. via the Hong Kong Stock Exchange on December 16, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments